Diversified Healthcare Trust [NASDAQ: DHC] surged by $0.07 during the normal trading session on Thursday and reaching a high of $4.335 during the day while it closed the day at $4.25. The company report on June 4, 2021 that Diversified Healthcare Trust Announces Annual Meeting Results.
Appoints Jennifer F. Francis as President and Chief Executive Officer.
Diversified Healthcare Trust (Nasdaq: DHC) announced the results of its 2021 Annual Meeting of Shareholders which was held yesterday. Additionally, the company has appointed Jennifer F. Francis as President and Chief Executive Officer, effective immediately. Ms. Francis has served as President and Chief Operating Officer since 2018. The results of the Annual Meeting of Shareholders were as follows.
Diversified Healthcare Trust stock has also gained 4.17% of its value over the past 7 days. However, DHC stock has declined by -10.53% in the 3 months of the year. Over the past six months meanwhile, it has gained 4.17% and gained 3.16% year-on date.
The market cap for DHC stock reached $1.00 billion, with 237.83 million shares outstanding and 235.09 million shares in the current float. Compared to the average trading volume of 1.36M shares, DHC reached a trading volume of 1501707 in the most recent trading day, which is why market watchdogs consider the stock to be active.
Here’s what leading stock market gurus have to say about Diversified Healthcare Trust [DHC]:
Based on careful and fact-backed analyses by Wall Street experts, the current consensus on the target price for DHC shares is $4.63 per share. Analysis on target price and performance of stocks is usually carefully studied by market experts, and the current Wall Street consensus on DHC stock is a recommendation set at 3.30. This rating represents a strong Buy recommendation, on the scale from 1 to 5, where 5 would mean strong sell, 4 represents Sell, 3 is Hold, and 2 indicates Buy.
Wells Fargo have made an estimate for Diversified Healthcare Trust shares, keeping their opinion on the stock as Underweight, with their previous recommendation back on December 10, 2020. The new note on the price target was released on June 08, 2020, representing the official price target for Diversified Healthcare Trust stock. Previously, the target price had yet another raise to $9, while Wells Fargo analysts kept a Equal Weight rating on DHC stock.
The Average True Range (ATR) for Diversified Healthcare Trust is set at 0.13, with the Price to Sales ratio for DHC stock in the period of the last 12 months amounting to 0.64. The Price to Book ratio for the last quarter was 0.42, with the Price to Cash per share for the same quarter was set at 3.58. Price to Free Cash Flow for DHC in the course of the last twelve months was 11.97.
DHC stock trade performance evaluation
Diversified Healthcare Trust [DHC] gain into the green zone at the end of the last week, gaining into a positive trend and gaining by 4.17. With this latest performance, DHC shares gained by 10.68% in over the last four-week period, additionally plugging by 4.17% over the last 6 months – not to mention a drop of -4.60% in the past year of trading.
Overbought and oversold stocks can be easily traced with the Relative Strength Index (RSI), where an RSI result of over 70 would be overbought, and any rate below 30 would indicate oversold conditions. An RSI rate of 50 would represent a neutral market momentum. The current RSI for DHC stock in for the last two-week period is set at 66.71, with the RSI for the last a single of trading hit 77.00, and the three-weeks RSI is set at 59.42 for Diversified Healthcare Trust [DHC]. The present Moving Average for the last 50 days of trading for this stock 3.97, while it was recorded at 4.17 for the last single week of trading, and 4.18 for the last 200 days.
Diversified Healthcare Trust [DHC]: An insightful look at the core fundamentals
Operating Margin for any stock indicates how profitable investing would be, and Diversified Healthcare Trust [DHC] shares currently have an operating margin of +7.89 and a Gross Margin at +7.73. Diversified Healthcare Trust’s Net Margin is presently recorded at -8.58.
Return on Total Capital for DHC is now 2.04, given the latest momentum, and Return on Invested Capital for the company is -2.41. Return on Equity for this stock declined to -5.33, with Return on Assets sitting at -2.12. When it comes to the capital structure of this company, Diversified Healthcare Trust [DHC] has a Total Debt to Total Equity ratio set at 140.19. Additionally, DHC Total Debt to Total Capital is recorded at 58.37, with Total Debt to Total Assets ending up at 54.02. Long-Term Debt to Equity for the company is recorded at 128.04, with the Long-Term Debt to Total Capital now at 53.31.
Receivables Turnover for the company is 30.43 with a Total Asset Turnover recorded at a value of 0.25.
Earnings per share (EPS) analysis for Diversified Healthcare Trust [DHC] stock
The progress of the company may be observed through the prism of EPS growth rate, while Wall Street analysts are focusing on predicting the 5-year EPS growth rate for DHC. When it comes to the mentioned value, analysts are expecting to see the 5-year EPS growth rate for Diversified Healthcare Trust go to 3.20%.
Diversified Healthcare Trust [DHC]: Insider Ownership positions
There are presently around $811 million, or 81.60% of DHC stock, in the hands of institutional investors. The top three institutional holders of DHC stocks are: BLACKROCK INC. with ownership of 44,868,603, which is approximately 3.567% of the company’s market cap and around 0.20% of the total institutional ownership; VANGUARD GROUP INC, holding 38,968,893 shares of the stock with an approximate value of $165.62 million in DHC stocks shares; and STATE STREET CORP, currently with $53.13 million in DHC stock with ownership of nearly -2.629% of the company’s market capitalization.
Positions in Diversified Healthcare Trust stocks held by institutional investors increased at the end of August and at the time of the August reporting period, where 100 institutional holders increased their position in Diversified Healthcare Trust [NASDAQ:DHC] by around 14,669,052 shares. Additionally, 119 investors decreased positions by around 12,242,384 shares, while 33 investors held positions by with 163,951,822 shares. The mentioned changes placed institutional holdings at 190,863,258 shares, according to the latest SEC report filing. DHC stock had 24 new institutional investments in for a total of 949,182 shares, while 29 institutional investors sold positions of 1,787,615 shares during the same period.